Taysha Gene Therapies, Inc.

TSHA·NasdaqGS·Healthcare
Compare
4.3600+0.2700 (+6.60%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market4.2500−0.1100 (−2.52%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.0900
Open4.0800
Day range4.00504.3800
52-week range3.45507.3000
Off day high−0.46%
Off 52-week high−40.27%
Volume3.68M
Avg. volume (3M)3.54M
Market cap1.42B
EPS (TTM)-0.4100
Forward P/E-9.43
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.31
Shares outstanding325.83M
Short interest15.98% of float
Earnings dateAug 11, 2026 (est.)
Analyst target13.0000
Profit margin0.00%

Against its peers

Compare in full ›
TSHA SRPT NGNE RGNX NTLA IONS
Market cap 1.42B 2.01B 551.91M 508.96M 1.72B 6.67B
P/E (TTM) — — — — — —
Forward P/E -9.4 7.8 -4.8 -2.6 -4.8 -35.0
Price/book 3.7 1.3 2.0 5.8 2.4 15.1
Dividend yield — — — — — —
1-year change +11.22% +7.65% +3.45% −30.98% −12.60% −45.82%
Today +6.60% +2.43% +3.41% +1.05% +3.79% −0.67%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All TSHA news ›

From the 4Search news index, newest first.

In the news

4mentions in 30 days
4with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance